News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–48
Matches
48
Sources here
9
Companies here
1
Search results Stored financial headlines

Active search

48 matching headlines

Ticker or company: MLABMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Mesa Laboratories, Inc. Revenue Breakdown – NASDAQ:MLAB

Mesa Laboratories, Inc. (NASDAQ: MLAB) generated $249.13 million USD in revenue last year, with its Sterilization and Disinfection Control segment being the top performer at $101.57 million USD. The majority of the company's revenue, $116.89 million USD, came from the United States.

MLAB main company
Sharemaestro market context Trend signal active 52 weeks +46.4% MLAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mesa Laboratories announces annual shareholder meeting

Mesa Laboratories will hold its annual shareholder meeting on September 8, 2026, in Lakewood, Colorado. Shareholders will vote on the election of seven directors, including John Sullivan and Siddhartha Kadia, and ratify Baker Tilly as the independent auditor. An advisory vote on executive compensation …

MLAB main company
Sharemaestro market context Trend signal active 52 weeks +46.4% MLAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mesa Laboratories, Inc. $MLAB Shares Purchased by Roubaix Capital LLC

Roubaix Capital LLC increased its stake in Mesa Laboratories (MLAB) by 30.7% in Q1 2026, making it their 10th largest holding. Despite this, analyst sentiment remains cautious with a "Reduce" consensus rating and a $94 price target. Recent financial results show Mesa Laboratories missed …

MLAB main company
Sharemaestro market context Trend signal active 52 weeks +46.4% MLAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mesa Laboratories (MLAB) Proxy Filing Summary

Mesa Laboratories (MLAB) reported strong financial performance in fiscal year 2025 with 12% revenue growth and 80% growth over five years. The company enhanced executive compensation, improved internal controls, and engaged with shareholders. Key voting matters included the election of seven director nominees, ratification …

MLAB main company
Sharemaestro market context Trend signal active 52 weeks +46.4% MLAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mesa Laboratories (MLAB) Q2 2025 earnings summary

Mesa Laboratories (MLAB) reported a strong Q2 2025, with revenues for the six months ended September 30, 2024, increasing 11.7% to $116.0 million, and net income soaring to $6.8 million from a prior year loss. The growth was primarily fueled by the GKE acquisition …

MLAB main company
Sharemaestro market context Trend signal active 52 weeks +46.4% MLAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context